Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China
· Delayed Price · Currency is CNY 23.26
-0.57 (-2.39%)
At close: Apr 29, 2026
SHA:688739 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 131.79 | 342.82 | 465.92 | 714.02 | 892.49 | Upgrade
|
| Depreciation & Amortization | 178.52 | 169.7 | 125.27 | 121.22 | 116.1 | Upgrade
|
| Other Amortization | 4.14 | 6.3 | 3.71 | 2.22 | 1.32 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | -0.09 | -2.48 | -0.04 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 69.43 | 1.8 | 0.87 | 0.83 | 0.71 | Upgrade
|
| Loss (Gain) From Sale of Investments | -15.93 | 60.02 | 20.27 | -27.25 | -14.2 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 8.66 | 12.77 | 15.08 | 16.44 | Upgrade
|
| Other Operating Activities | 8.36 | 33.21 | 55.43 | 7.98 | 8.11 | Upgrade
|
| Change in Accounts Receivable | 18.39 | -18.02 | 13.82 | -156.41 | -436.49 | Upgrade
|
| Change in Inventory | -52.76 | -73.27 | 0.42 | -104.11 | -109.74 | Upgrade
|
| Change in Accounts Payable | -2.71 | -27.59 | -11.84 | -17.55 | 45.15 | Upgrade
|
| Change in Other Net Operating Assets | 0.13 | 0.06 | 0.06 | 0.08 | 0.1 | Upgrade
|
| Operating Cash Flow | 340.86 | 500.96 | 677.01 | 546.49 | 506.38 | Upgrade
|
| Operating Cash Flow Growth | -31.96% | -26.00% | 23.88% | 7.92% | -41.09% | Upgrade
|
| Capital Expenditures | -308.08 | -362.48 | -551.99 | -511.61 | -508.35 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 10.98 | 0.02 | 0.15 | 0.02 | Upgrade
|
| Cash Acquisitions | - | -0.06 | -0.06 | -0.08 | -0.09 | Upgrade
|
| Investment in Securities | 154.4 | 156.81 | -883.2 | 3,327 | -2,598 | Upgrade
|
| Other Investing Activities | 26.81 | 31.92 | 32.95 | 75.04 | 40.72 | Upgrade
|
| Investing Cash Flow | -126.88 | -162.83 | -1,402 | 2,890 | -3,066 | Upgrade
|
| Long-Term Debt Repaid | - | -5.85 | -6.38 | -5.41 | -5.63 | Upgrade
|
| Net Debt Issued (Repaid) | - | -5.85 | -6.38 | -5.41 | -5.63 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 4,371 | Upgrade
|
| Repurchase of Common Stock | - | -50 | -99.99 | - | - | Upgrade
|
| Common Dividends Paid | -329.23 | -329.38 | -416.32 | -416.3 | - | Upgrade
|
| Dividends Paid | -329.23 | -329.38 | -416.32 | -416.3 | - | Upgrade
|
| Other Financing Activities | -17.3 | - | - | - | -18.95 | Upgrade
|
| Financing Cash Flow | -346.53 | -385.23 | -522.69 | -421.7 | 4,347 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.69 | 0.55 | 2.29 | 1.58 | -0.36 | Upgrade
|
| Net Cash Flow | -131.86 | -46.55 | -1,246 | 3,017 | 1,787 | Upgrade
|
| Free Cash Flow | 32.78 | 138.48 | 125.02 | 34.89 | -1.97 | Upgrade
|
| Free Cash Flow Growth | -76.33% | 10.76% | 258.36% | - | - | Upgrade
|
| Free Cash Flow Margin | 2.36% | 8.26% | 7.14% | 1.92% | -0.09% | Upgrade
|
| Free Cash Flow Per Share | 0.08 | 0.34 | 0.30 | 0.08 | -0.01 | Upgrade
|
| Cash Income Tax Paid | 94.29 | 177.45 | 182.09 | 211.18 | 198.48 | Upgrade
|
| Levered Free Cash Flow | -82.53 | 52.09 | 46.39 | -182.35 | -228.08 | Upgrade
|
| Unlevered Free Cash Flow | -82.53 | 53.08 | 47.28 | -181.53 | -227.12 | Upgrade
|
| Change in Working Capital | -35.44 | -121.46 | -4.75 | -287.57 | -514.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.